Estrogen sulfotransferase/SULT1E1 promotes human adipogenesis

Molecular and Cellular Biology

Volumn 34, Issue 9, 2014, Pages 1682-1694

  Ihunnah, Chibueze A ^a   Wada, Taira ^a   Philips, Brian J ^b   Ravuri, Sudheer K ^b   Gibbs, Robert B ^a   Kirisci, Levent ^a   Rubin, J Peter ^b   Marra, Kacey G ^b   Xie, Wen ^a,c  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b MCGOWAN INSTITUTE FOR REGENERATIVE MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN SULFOTRANSFERASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ABDOMINAL SUBCUTANEOUS FAT; ADIPOGENESIS; ADIPOSE DERIVED STEM CELL; ADIPOSE TISSUE; ARTICLE; BODY MASS; CELL DIFFERENTIATION; CELL ISOLATION; CONTROLLED STUDY; ENZYME ACTIVITY; GENE OVEREXPRESSION; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROADIPOCYTE; PROMOTER REGION; PROTEIN EXPRESSION;

ADIPOCYTES; ADIPOGENESIS; ADIPOSITY; ADULT; CELLS, CULTURED; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE KNOCKDOWN TECHNIQUES; HUMANS; MALE; MIDDLE AGED; SULFOTRANSFERASES; UP-REGULATION;

EID: 84897569023     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.01147-13     Document Type: Article

References (40)

1. Zammit C, Liddicoat H, Moonsie I, Makker H. 2010. Obesity and respiratory diseases. Int. J. Gen. Med. 3:335-343. http://dx.doi.org/10.2147/IJGM.S11926.
2. Rayalam S, Della-Fera MA, Baile CA. 2008. Phytochemicals and regulation of the adipocyte life cycle. J. Nutr. Biochem. 19:717-726. http://dx.doi.org/10.1016/j.jnutbio.2007.12.007.
3. Gregoire FM, Smas CM, Sul HS. 1998. Understanding adipocyte differentiation. Physiol. Rev. 78:783-809.
4. Gregoire FM. 2001. Adipocyte differentiation: from fibroblast to endocrine cell. Exp. Biol. Med. (Maywood) 226:997-1002.
5. Mayes JS, Watson GH. 2004. Direct effects of sex steroid hormones on adipose tissues and obesity. Obes. Rev. 5:197-216. http://dx.doi.org/10.1111/j.1467-789X.2004.00152.x.
6. Mueller SO, Korach KS. 2001. Estrogen receptors and endocrine diseases: lessons from estrogen receptor knockout mice. Curr. Opin. Pharmacol. 1:613-619. http://dx.doi.org/10.1016/S1471-4892(01)00105-9.
7. Couse JF, Korach KS. 1999. Estrogen receptor null mice: what have we learned and where will they lead us? Endocr. Rev. 20:358-417. http://dx.doi.org/10.1210/edrv.20.3.0370.
8. Jones ME, Thorburn AW, Britt KL, Hewitt KN, Wreford NG, Proietto J, Oz OK, Leury BJ, Robertson KM, Yao S, Simpson ER. 2000. Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proc. Natl. Acad. Sci. U. S. A. 97:12735-12740. http://dx.doi.org/10.1073/pnas.97.23.12735.
9. D'Eon TM, Souza SC, Aronovitz M, Obin MS, Fried SK, Greenberg AS. 2005. Estrogen regulation of adiposity and fuel partitioning. Evidence of genomic and non-genomic regulation of lipogenic and oxidative pathways. J. Biol. Chem. 280:35983-35991. http://dx.doi.org/10.1074/jbc.M50 7339200.
10. Salpeter SR, Walsh JME, Ormiston TM, Greyber E, Buckley NS, Salpeter EE. 2006. Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women. Diabetes Obes. Metab. 8:538-554. http://dx.doi.org/10.1111/j.1463-1326.2005.00545.x.
11. Davis SR, Castelo-Branco C, Chedraui P, Lumsden MA, Nappi RE, Shah D, Villaseca P, Writing Group of the International Menopause Society for World Menopause Day 2012. 2012. Understanding weight gain at menopause. Climacteric 15:419-429. http://dx.doi.org/10.3109/13697137.2012.707385.
12. Song WC. 2001. Biochemistry and reproductive endocrinology of estrogen sulfotransferase. Ann. N. Y. Acad. Sci. 948:43-50. http://dx.doi.org/10.1111/j.1749-6632.2001.tb03985.x.
13. Wada T, Ihunnah CA, Gao J, Chai X, Zeng S, Philips BJ, Rubin JP, Marra KG, Xie W. 2011. Estrogen sulfotransferase inhibits adipocyte differentiation. Mol. Endocrinol. 25:1612-1623. http://dx.doi.org/10.1210/me.2011-1089.
14. Gerlach JC, Lin YC, Brayfield CA, Minteer DM, Li H, Rubin JP, Marra KG. 2012. Adipogenesis of human adipose-derived stem cells within three-dimensional hollow fiber-based bioreactors. Tissue Eng. Part C Methods 18:54-61. http://dx.doi.org/10.1089/ten.tec.2011.0216.
15. Ho SN, Hunt HD, Horton RM, Pullen JK, Pease LR. 1989. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77:51-59. http://dx.doi.org/10.1016/0378-1119(89)90358-2.
16. Nelson JD, Denisenko O, Bomsztyk K. 2006. Protocol for the fast chromatin immunoprecipitation (ChIP) method. Nat. Protoc. 1:179-185. http://dx.doi.org/10.1038/nprot.2006.27.
17. Rangwala SM, Lazar MA. 2000. Transcriptional control of adipogenesis. Annu. Rev. Nutr. 20:535-559. http://dx.doi.org/10.1146/annurev.nutr.20.1.535.
18. Cao Z, Umek RM, McKnight SL. 1991. Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev. 5:1538-1552. http://dx.doi.org/10.1101/gad.5.9.1538.
19. Hwang CS, Mandrup S, MacDougald OA, Geiman DE, Lane MD. 1996. Transcriptional activation of the mouse obese (ob) gene by CCAAT/enhancer binding protein alpha. Proc. Natl. Acad. Sci. U. S. A. 93:873-877. http://dx.doi.org/10.1073/pnas.93.2.873.
20. Ross SR, Graves RA, Greenstein A, Platt KA, Shyu HL, Mellovitz B, Spiegelman BM. 1990. A fat-specific enhancer is the primary determinant of gene expression for adipocyte P2 in vivo. Proc. Natl. Acad. Sci. U. S. A. 87:9590-9594. http://dx.doi.org/10.1073/pnas.87.24.9590.
21. Wu Z, Bucher NL, Farmer SR. 1996. Induction of peroxisome proliferator-activated receptor gamma during the conversion of 3T3 fibroblasts into adipocytes is mediated by C/EBPβ, C/EBPδ, and glucocorticoids. Mol. Cell. Biol. 16:4128-4136.
22. Wu Z, Xie Y, Bucher NL, Farmer SR. 1995. Conditional ectopic expression of C/EBP beta in NIH-3T3 cells induces PPAR gamma and stimulates adipogenesis. Genes Dev. 9:2350-2363. http://dx.doi.org/10.1101/gad.9.19.2350.
23. Miki H, Yamauchi T, Suzuki R, Komeda K, Tsuchida A, Kubota N, Terauchi Y, Kamon J, Kaburagi Y, Matsui J, Akanuma Y, Nagai R, Kimura S, Tobe K, Kadowaki T. 2001. Essential role of insulin receptor substrate 1 (IRS-1) and IRS-2 in adipocyte differentiation. Mol. Cell. Biol. 21:2521-2532. http://dx.doi.org/10.1128/MCB.21.7.2521-2532.2001.
24. Font de Mora J, Porras A, Ahn N, Santos E. 1997. Mitogen-activated protein kinase activation is not necessary for, but antagonizes, 3T3-L1 adipocytic differentiation. Mol. Cell. Biol. 17:6068-6075.
25. Sale EM, Atkinson PG, Sale GJ. 1995. Requirement of MAP kinase for differentiation of fibroblasts to adipocytes, for insulin activation of p90 S6 kinase and for insulin or serum stimulation of DNA synthesis. EMBO J. 14:674-684.
26. Komatsu K, Driscoll WJ, Koh YC, Strott CA. 1994. A P-loop related motif (GxxGxxK) highly conserved in sulfotransferases is required for binding the activated sulfate donor. Biochem. Biophys. Res. Commun. 204:1178-1185. http://dx.doi.org/10.1006/bbrc.1994.2587.
27. Wang LQ, Falany CN, James MO. 2004. Triclosan as a substrate and inhibitor of 3'-phosphoadenosine 5'-phosphosulfate-sulfotransferase and UDP-glucuronosyl transferase in human liver fractions. Drug Metab. Dispos. 32:1162-1169. http://dx.doi.org/10.1124/dmd.104.000273.
28. Zhang H, Varlamova O, Vargas FM, Falany CN, Leyh TS. 1998. Sulfuryl transfer: the catalytic mechanism of human estrogen sulfotransferase. J. Biol. Chem. 273:10888-10892. http://dx.doi.org/10.1074/jbc.273.18.10888.
29. Joyner JM, Hutley LJ, Cameron DP. 2001. Estrogen receptors in human preadipocytes. Endocrine 15:225-230. http://dx.doi.org/10.1385/ENDO: 15:2:225.
30. Cardoso F, Bischoff J, Brain E, Zotano AG, Luck H-J, Tjan-Heijnen VC, Tanner M, Aapro M. 2013. A review of the treatment of endocrine responsive metastatic breast cancer in postmenopausal women. Cancer Treat. Rev. 39:457-465. http://dx.doi.org/10.1016/j.ctrv.2012.06.011.
31. Anghel SI, Wahli W. 2007. Fat poetry: a kingdom for PPAR gamma. Cell Res. 17:486-511. http://dx.doi.org/10.1038/cr.2007.48.
32. Spiegelman BM. 1998. PPAR-gamma: adipogenic regulator and thiazolidinedione receptor. Diabetes 47:507-514. http://dx.doi.org/10.2337/diabetes.47.4.507.
33. Cooke PS, Naaz A. 2005. Effects of estrogens and the phytoestrogen genistein on adipogenesis and lipogenesis in males and females. Birth Defects Res. A Clin. Mol. Teratol. 73:472-473. http://dx.doi.org/10.1002/bdra.20142.
34. Heine PA, Taylor JA, Iwamoto GA, Lubahn DB, Cooke PS. 2000. Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proc. Natl. Acad. Sci. U. S. A. 97:12729-12734. http://dx.doi.org/10.1073/pnas.97.23.12729.
35. Lundholm L, Zang H, Hirschberg AL, Gustafsson J-A, Arner P, Dahlman-Wright K. 2008. Key lipogenic gene expression can be decreased by estrogen in human adipose tissue. Fertil. Steril. 90:44-48. http://dx.doi.org/10.1016/j.fertnstert.2007.06.011.
36. Arner P, Spalding KL. 2010. Fat cell turnover in humans. Biochem. Biophys. Res. Commun. 396:101-104. http://dx.doi.org/10.1016/j.bbrc.2010.02.165.
37. Spalding KL, Arner E, Westermark PO, Bernard S, Buchholz BA, Bergmann O, Blomqvist L, Hoffstedt J, Naslund E, Britton T, Concha H, Hassan M, Ryden M, Frisen J, Arner P. 2008. Dynamics of fat cell turnover in humans. Nature 453:783-787. http://dx.doi.org/10.1038/nature06902.
38. Hernandez TL, Kittelson JM, Law CK, Ketch LL, Stob NR, Lindstrom RC, Scherzinger A, Stamm ER, Eckel RH. 2011. Fat redistribution following suction lipectomy: defense of body fat and patterns of restoration. Obesity 19:1388-1395. http://dx.doi.org/10.1038/oby.2011.64.
39. Rigamonti A, Brennand K, Lau F, Cowan CA. 2011. Rapid cellular turnover in adipose tissue. PLoS One 6:e17637. http://dx.doi.org/10.1371/journal.pone.0017637.
40. James MO, Li W, Summerlot DP, Rowland-Faux L, Wood CE. 2010. Triclosan is a potent inhibitor of estradiol and estrone sulfonation in sheep placenta. Environ. Int. 36:942-949. http://dx.doi.org/10.1016/j.envint.2009.02.004.